Clinical Trial Update: A Single-center, Self-controlled, Prospective Case Series Pilot Study to Assess the Effect of Lamivudine (3TC) on Neurocognitive Impairment Biomarkers and Type-I IFN (Interferon)-Stimulated Genes in the Plasma of Patients With Mild Cognitive Impairment (MCI) [Phase 2]

View source ↗

Summary

A Phase 2 pilot, single-center, self-controlled study to assess the effect of lamivudine (3TC) on neurocognitive impairment biomarkers and Type I IFN-stimulated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Lamivudine (lamivudine)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: Mild Cognitive Impairment | Phase 2 | Status: ACTIVE_NOT_RECRUITING